ICU Medical, Inc. (ICUI)

Market Cap	3.18B -8.7%
Revenue (ttm)	2.23B -6.3%
Net Income	732,000
EPS	0.03
Shares Out	24.99M
PE Ratio	4,287.21
Forward PE	74.77
Dividend	n/a
Ex-Dividend Date	n/a

Volume	176,808
Open	128.85
Previous Close	128.15
Day's Range	125.70 - 130.30
52-Week Range	107.00 - 160.29
Beta	0.85
Analysts	Strong Buy
Price Target	174.33 (+36.88%)
Earnings Date	May 7, 2026

About ICUI

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinf...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Mar 31, 1992
• Employees: 13,000
• Stock Exchange: NASDAQ
• Ticker Symbol: ICUI
• Website: https://www.icumed.com

Analyst Summary

According to 3 analysts, the average rating for ICUI stock is "Strong Buy." The 12-month stock price target is $174.33, which is an increase of 36.88% from the latest price.

Price Target

$174.33

(36.88% upside)

Analyst Consensus: Strong Buy